High Qulity L-carnitine

  Product Detail  

1. Core Molecular & Physicochemical Specifications

2. Mechanism of Action

1. Mitochondrial Fatty Acid Shuttle
   
   
   • Long-chain fatty acids in the cytosol are activated to fatty acyl-CoA by acyl-CoA synthetase.
   • L-carnitine reacts with fatty acyl-CoA to form fatty acyl-carnitine (catalyzed by carnitine palmitoyltransferase I, CPT I), which crosses the mitochondrial inner membrane via the carnitine-acylcarnitine translocase (CACT).
   • Inside the mitochondria, carnitine palmitoyltransferase II (CPT II) converts fatty acyl-carnitine back to fatty acyl-CoA and free L-carnitine (recycled to the cytosol), enabling β-oxidation of fatty acids to produce ATP.
   
   
2. Secondary Metabolic & Protective Effects
   
   
   • Lactate Clearance: Promotes lactate transport out of muscle cells, reducing exercise-induced lactic acid buildup and delaying fatigue.
   • Antioxidant Activity: Scavenges reactive oxygen species (ROS) in mitochondria; stabilizes the mitochondrial membrane to prevent apoptosis.
   • Ammonia Detoxification: Conjugates with acetyl-CoA to form acetylcarnitine, reducing excess acetyl-CoA accumulation and mitigating ammonia toxicity in liver and muscle tissue.
   
   

3. Biological Functions & Application Fields

3.1 Core Physiological Effects

• Energy Production: Enhances mitochondrial β-oxidation, increasing fat-derived ATP synthesis—critical for cardiac muscle, skeletal muscle, and liver function.
• Exercise Performance & Recovery: Reduces fatigue, improves endurance, and accelerates post-exercise recovery by clearing lactate and supporting muscle energy metabolism.
• Weight Management: Promotes fat breakdown and reduces fat accumulation; may enhance resting energy expenditure (REE) in obese populations.
• Cardioprotection: Improves cardiac function in heart failure by optimizing energy supply; reduces myocardial ischemia-reperfusion injury via antioxidant effects.
• Neuroprotection: Supports brain energy metabolism; may alleviate symptoms of neurodegenerative diseases (e.g., Alzheimer’s) by reducing oxidative stress and improving mitochondrial function.

3.2 Application Fields

4. Production & Quality Control

4.1 Manufacturing Processes

1. Chemical Synthesis
   
   
   • Racemic carnitine (DL-carnitine) is synthesized from trimethylamine and epichlorohydrin, then resolved into L-carnitine via chiral separation (e.g., enzymatic hydrolysis or chiral chromatography).
   • High yield, low cost; dominant method for industrial production.
   
   
2. Microbial Fermentation
   
   
   • Uses engineered strains (e.g., Escherichia coli, Corynebacterium glutamicum) to synthesize L-carnitine from glucose or amino acid precursors.
   • High enantiomeric purity (≥99.9% L-carnitine); suitable for pharmaceutical-grade production.
   
   
3. Extraction from Natural Sources
   
   
   • Extracted from animal tissues (e.g., skeletal muscle, liver, kidney)—rich in L-carnitine.
   • Low yield, high cost; limited to small-scale, natural-label products.
   
   

4.2 Quality Testing Standards

5. Administration, Safety & Precautions

5.1 Administration Routes & Dosage

5.2 Safety Profile

• Low Toxicity: LD₅₀ >15 g/kg in rodents; no acute toxicity reported in humans at therapeutic doses.
• Common Side Effects: Mild gastrointestinal discomfort (nausea, diarrhea, abdominal cramps) at doses >3 g/day; transient fishy body odor (due to trimethylamine metabolism in some individuals).
• Rare Adverse Events: Hypoglycemia (in diabetics on insulin); muscle cramps (rare, linked to rapid dosage escalation).
• Contraindications: Hypersensitivity to L-carnitine; caution in patients with severe renal impairment (risk of accumulation).
• Drug Interactions: May enhance the efficacy of anticoagulants (monitor INR); avoid concurrent use with valproic acid (reduces carnitine levels).

5.3 Handling Guidelines

• Storage: Store crystalline powder in a cool, dry place (20–25°C); protect from moisture and direct sunlight.
• Formulation Compatibility: Compatible with water, juices, and most supplement formulations; avoid mixing with strong acids or oxidants.

6. Key Advantages & Limitations

6.1 Advantages

1. Endogenous Origin: Synthesized in the body; supplementation is well-tolerated with minimal side effects.
2. Multi-Tissue Utility: Supports energy metabolism in muscle, heart, liver, and brain—broad clinical and nutritional applications.
3. High Bioavailability: Oral absorption is ~50–80% (enhanced by food, especially fat-containing meals); IV administration achieves 100% bioavailability.
4. Safe for Long-Term Use: No cumulative toxicity reported in long-term supplementation (up to 2 years).

6.2 Limitations

1. Diminishing Returns: Supplementation has limited benefits in individuals with normal endogenous L-carnitine levels.
2. Cost Variability: Pharmaceutical-grade L-carnitine (high enantiomeric purity) is more expensive than food-grade formulations.
3. Odor Issue: A subset of users experiences fishy body odor due to genetic variations in trimethylamine metabolism.

 About Us 

  Product Detail  

  Product Detail